Market Expansion:
Public materials and profiles indicate adoption has grown to cover a majority of U.S. clinics between 2022 and 2024, pointing to continued penetration across the domestic market.
Product Line Growth:
The platform has expanded beyond procurement into a Home Delivery pharmacy and is rolling out integrations with major practice‑management systems, broadening its operational footprint.
Strategic Partnerships:
Industry and association pages show Vetcove listed as a member benefit and purchasing channel alongside major distributors and manufacturers, indicating broad partner presence.
